Search

Your search keyword '"Joy D. Cogan"' showing total 134 results

Search Constraints

Start Over You searched for: Author "Joy D. Cogan" Remove constraint Author: "Joy D. Cogan"
134 results on '"Joy D. Cogan"'

Search Results

1. A review of multiple diagnostic approaches in the undiagnosed diseases network to identify inherited metabolic diseases

2. Review and metabolomic profiling of unsolved case reveals newly reported autosomal dominant congenital disorder of glycosylation, type Iw formerly thought to only be an autosomal recessive condition

3. Personalized structural biology reveals the molecular mechanisms underlying heterogeneous epileptic phenotypes caused by de novo KCNC2 variants

4. Lessons learned: next-generation sequencing applied to undiagnosed genetic diseases

5. Low-grade albuminuria in pulmonary arterial hypertension

7. The Genetic Landscape of Familial Pulmonary Fibrosis

11. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

12. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

13. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

14. The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis

15. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

16. Familial Autonomic Ganglionopathy Caused by Rare CHRNA3 Genetic Variants

17. A concurrent dual analysis of genomic data augments diagnoses: Experiences of 2 clinical sites in the Undiagnosed Diseases Network

18. One is the loneliest number: genotypic matchmaking using the electronic health record

19. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

20. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

21. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

22. Limitations of exome sequencing in detecting rare and undiagnosed diseases

23. WebSeq: A Genomic Data Analytics Platform for Monogenic Disease Discovery

24. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

25. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

26. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

27. An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

28. AMELIE 3: Fully Automated Mendelian Patient Reanalysis at Under 1 Alert per Patient per Year

29. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5

30. Identifying digenic disease genes via machine learning in the Undiagnosed Diseases Network

31. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

33. Identifying digenic disease genes using machine learning in the undiagnosed diseases network

34. Occupational and Environmental Exposures Associated with Increased Risk of Interstitial Lung Abnormalities in Individuals at Risk for Familial Interstitial Pneumonia

35. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease

36. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

37. HACER: an atlas of human active enhancers to interpret regulatory variants

38. Phenotype risk scores identify patients with unrecognized Mendelian disease patterns

39. Phenotypic heterogeneity of ZMPSTE24 deficiency

40. Three-dimensional spatial analysis of missense variants in RTEL1 identifies pathogenic variants in patients with Familial Interstitial Pneumonia

41. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

42. Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

43. Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families

44. Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis

45. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

46. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

47. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3

48. The Y Chromosome Regulates BMPR2 Expression via SRY: A Possible Reason 'Why' Fewer Males Develop Pulmonary Arterial Hypertension

49. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

50. Abstract P176: Familial Autonomic Ganglionopathy Caused by Rare CHRNA3 Genetic Variants. Novel Genetic Cause of Neurogenic Orthostatic Hypotension

Catalog

Books, media, physical & digital resources